ID   SK-MEL-94
AC   CVCL_3880
SY   SK-Mel-94; SKMEL94
DR   cancercelllines; CVCL_3880
DR   Cosmic; 685205
DR   Cosmic; 1122256
DR   GEO; GSM555125
DR   GEO; GSM555178
DR   Lonza; 1335
DR   Progenetix; CVCL_3880
DR   Wikidata; Q54954349
RX   PubMed=7747814;
RX   PubMed=18505964;
RX   PubMed=21343389;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=18505964).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=7747814; PMCID=PMC1869278;
RA   Gruis N.A., Weaver-Feldhaus J.M., Liu Q.-Y., Frye C., Eeles R., Orlow I.,
RA   Lacombe L., Ponce-Castaneda V., Lianes P., Latres E., Skolnick M.H.,
RA   Cordon-Cardo C., Kamb A.;
RT   "Genetic evidence in melanoma and bladder cancers that p16 and p53
RT   function in separate pathways of tumor suppression.";
RL   Am. J. Pathol. 146:1199-1206(1995).
//
RX   PubMed=18505964; DOI=10.1093/jnci/djn157; PMCID=PMC4410798;
RA   Freedberg D.E., Rigas S.H., Russak J.E., Gai W.-M., Kaplow M.E.,
RA   Osman I., Turner F., Randerson-Moor J.A., Houghton A.N., Busam K.J.,
RA   Bishop D.T., Bastian B.C., Newton-Bishop J.A., Polsky D.;
RT   "Frequent p16-independent inactivation of p14ARF in human melanoma.";
RL   J. Natl. Cancer Inst. 100:784-795(2008).
//
RX   PubMed=21343389; DOI=10.1158/0008-5472.CAN-10-2958; PMCID=PMC3070783;
RA   Rose A.E., Poliseno L., Wang J.-H., Clark M., Pearlman A., Wang G.-M.,
RA   Vega y Saenz de Miera E.C., Medicherla R., Christos P.J., Shapiro R.,
RA   Pavlick A., Darvishian F., Zavadil J., Polsky D., Hernando E.,
RA   Ostrer H., Osman I.;
RT   "Integrative genomics identifies molecular alterations that challenge
RT   the linear model of melanoma progression.";
RL   Cancer Res. 71:2561-2571(2011).
//